Apuli Maricel sold BBIO
February 26, 2026 · Form 4 insider transaction
Apuli Maricel sold 2,000 shares of BridgeBio Pharma, Inc. at $66.00 per share, a transaction worth $132.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,000
Price
$66.00
Total value
$132.0K
InsiderApuli Maricel
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after121,945
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.